Kolexia
Bareau Benoit Hématologie
Bareau Benoit
Hématologie
Centre hospitalier Privé-Sévigné
Cesson-Sévigné, France
45 Activités
178 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie à grands lymphocytes granuleux Vascularite Macroglobulinémie de Waldenström Myélome multiple Syndromes myéloprolifératifs Thromboembolie Thromboembolisme veineux Syndromes lymphoprolifératifs

Collaborateurs

Voir plus
Lamy De La Chapelle Thierry
Lamy De La Chapelle Thierry
Hôpital Pontchaillou, Rennes, France
Laribi Kamel
Laribi Kamel
Centre Hospitalier du Mans, Le Mans, France
Roussel Mikael
Roussel Mikael
Hôpital Pontchaillou, Rennes, France
Launay Vincent
Launay Vincent
Centre Hospitalier de Saint Brieuc, Saint-Brieuc, France

Industries

Voir plus
A+A
56 collaboration(s)
Dernière en 2023
Janssen
7 collaboration(s)
Dernière en 2023
Zeste Research
4 collaboration(s)
Dernière en 2022
Abbvie
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Multicenter Open Label Phase 3 Benefit Study of Isatuximab Plus Lenalidomide and Dexamethasone with/without Bortezomib in the Treatment of Newly Diagnosed Non-Frail Transplant Ineligible Multiple Myeloma Elderly Patients. IFM2020-05
65th ASH Annual Meeting Abstracts   02 novembre 2023
Ixazomib, Pomalidomide and Dexamethasone (IxPd) in Relapsed or Refractory Multiple Myeloma (RRMM) Characterized with High-Risk Cytogenetics. IFM 2014-01
65th ASH Annual Meeting Abstracts   02 novembre 2023
AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms
Essai Clinique (CHU Brest)   27 octobre 2023
Long-Term Follow-up of Bendamustine Plus Rituximab Regimen in 69 Treatment Naïve (TN) Patients with Waldenström Macroglobulinemia, a Study on Behalf of the French Innovative Leukemia Organization (FILO)
Annual Meeting Abstracts 2022   15 novembre 2022
Apixaban for the prevention of thromboembolism in immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study.
American journal of hematology   01 avril 2019
Bendamustine plus rituximab in newly-diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).
British journal of haematology   12 décembre 2018
Switches of tyrosine-kinase inhibitors in chronic phase of chronic myeloid leukemia in real life.
American journal of hematology   30 septembre 2018
The Bendamustine Plus Rituximab Regimen Is Active and Safe in Previously Untreated Patients with Waldenström Macroglobulinemia, a Study on Behalf of the French Innovative Leukemia Organization (FILO)
Blood   08 décembre 2017
Non-tropical endomyocardial fibrosis: A rare cause of bi-apical filling.
Diagnostic and interventional imaging   09 octobre 2015
Poster Presentations
13‐ICML, 13th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano (Switzerland), 17‐20 June, 2015   09 juin 2015